Bullish on Federal Reform
|
Cannabis Rescheduling Nearly ‘Done Deal,’ Story Cannabis CEO Says |
Jason Vedadi, the former executive chairman for Harvest Health before its acquisition by Trulieve, talks exclusively with CBT on what he expects from federal rescheduling as the industry awaits the DEA’s final determination. More >>> |
Where's the Applications?
|
Hundreds Interested in Kentucky’s Medical Cannabis Licenses; Just 17 Apply So Far |
Seventeen interested parties applied in the first three weeks of the two-month application period. There are 74 licenses available in a lottery system. More >>> |
|
Lessons in Cannabis Patent and Trademark Protection |
Tips and insights from Kenneth Morrow’s experiences in patenting and trademarking in cannabis, and how one recent case may have established an important precedent. More >>> |
|
Special Report: 4 in 5 Cannabis Businesses Want Intoxicating Hemp Regulated; So Do Nearly 50% of Hemp Businesses |
CBT’s new research reveals that 80% of cannabis businesses and 46% of hemp businesses feel intoxicating hemp-derived cannabinoids should be regulated like cannabis. Find these and other details about how the cannabis and hemp industries view intoxicating hemp-derived cannabinoids in Part I of this two-part special report. More >>> |
About CBT: Cannabis Business Times is the most trusted source of actionable intelligence for plant-touching cannabis businesses throughout North America. |